FDA Matters logo
  • Blog
  • About
  • Media
Picking Apart the Destructive Claim That Industry Controls FDA 

Picking Apart the Destructive Claim That Industry Controls FDA 

by Steven Grossman | May 12, 2025 | Short Takes and Updates

I am tired of the continued defamation of FDA as an agency controlled by industry. That is not to say that FDA is perfect or that there have never been FDA-industry interactions that looked (and maybe were) bad. However, as a generalization….no, FDA is not...
Picking Apart the Destructive Claim That Industry Controls FDA 

New CBER Leadership: The FDA Matters Analysis

by Steven Grossman | May 8, 2025 | Short Takes and Updates

The headline, “Dr. Prasad to succeed Peter Marks as CBER director,” spread like wildfire Tuesday night after Endpoints News broke the story. Reactions ranged from “Omigod, he’ll destroy the industry and the hopes of patients” to “no big deal, staff do the product...
Picking Apart the Destructive Claim That Industry Controls FDA 

Truth-Telling: FDA User Fee Edition

by Steven Grossman | May 2, 2025 | Short Takes and Updates

After 50 years in Washington, I have no expectation of being told the truth by government officials—elected or appointed. I like to think I have seen it all—shading the truth, burying the truth, plausibly deniable truth, and sometimes things entirely made up and...
Picking Apart the Destructive Claim That Industry Controls FDA 

The American People in the Hands of an Indifferent Government

by Steven Grossman | Apr 29, 2025 | Short Takes and Updates

Several decades ago, when I was a Senate staffer, I observed that I could spend the entire Gross Domestic Product on the good ideas that people brought to us. I soon learned that lawmaking requires a substantial amount of restraint and a lot of prioritizing. Those are...
Picking Apart the Destructive Claim That Industry Controls FDA 

How Many People Still Work for FDA & Other FDA Thoughts

by Steven Grossman | Apr 25, 2025 | Short Takes and Updates

FDA’s responsibilities have not changed since January 20th. However, its capacity to carry out its duties has been meaningfully reduced by the Administration’s downsizing. We should all be able to agree on that. It has not been clear how many people still work...
« Older Entries
Next Entries »

Recent Posts

  • Chairman Cassidy: Please Ask Dr. Overton About FDA Decision-Making
  • The FDA’s Century-Long Campaign to Assure Safe Manufacturing (Part 2)
  • The FDA’s Century-Long Campaign to Assure Safe Drug Manufacturing (Part 1)
  • A Marathon, Not a Sprint: The Long Road to Becoming the Next FDA Commissioner
  • Firing Dr. Makary Solves No Problems….BUT Opens the Door for More Orderly Management and Decision-Making

Recent Comments

No comments to show.
FDA Matters logo

 ©2009-2026 FDA Matters | FDA Matters does not report the news….we provide analysis of what’s behind the news.

We sometimes use artificial intelligence in drafting columns, primarily using Claude AI and Microsoft Co-Pilot. We review and verify all findings, interpretations, and final wording.